Crohn's disease is a serious long-term condition affecting hundreds of thousands of people in this country and gets a lot of ...

Circular Genomics recently moved its headquarters to Lilly Gateway Labs, aiming to enhance its Alzheimer's disease ...

Several medications now calm painful inflammation in the intestines. Diets free of ultraprocessed foods also help ...

Fact checked by Nick Blackmer Crohn's disease might not affect someone only physically—it can have mental health implications ...

How many deaths have been linked to the mystery disease in Congo? At least 60 deaths have been reported, according to the latest bulletin from the WHO's Africa office. In the initial outbreak ...

The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's disease in adults. Crohn's disease, also known as ...

2 1. FDA approves Lilly’s Omvoh® (mirikizumab-mrkz) for Crohn’s disease, expanding its use to the second major type of inflammatory bowel disease. News release. Eli Lilly and Company.

Fatigue is a common symptom of Crohn’s disease, a type of inflammatory bowel disease (IBD). Treating the condition with medication and lifestyle adjustments can help with fatigue. But it’s ...

At a population level, it remains our most harmful infectious disease, with thousands of hospitalisations and 664 deaths last year. Understandably perhaps, many people want to move on from the ...

In other Lilly news, the FDA recently approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's disease in adults. The drug is is now approved in the United States ...

After news about MSNBC canceling Joy Reid's evening news show was leaked to the press, the outlet's new president, Rebecca Kutler, called a meeting with Reid's staff on February 23, 2025.